Latest California Healthline Stories
Durante la inscripción de ACA, elegir un plan genera nuevas complicaciones de COVID
Las personas que compran su propio seguro médico enfrentan desafíos, en particular los pacientes que tuvieron COVID-19 y que presentan problemas de salud persistentes.
Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.
Savvy Patient Fought for the Price She Was Quoted − And Didn’t Give Up
A California woman thought the discount on her coinsurance before an operation sounded too good to be true. Turns out, she was right.
Promises Kept? On Health Care, Trump’s Claims of ‘Monumental Steps’ Don’t Add Up
The president entered office seeking to overturn the Affordable Care Act, revamp Medicaid and drive down prescription drug prices, among other things. He’s hit some stone walls.
With No Legal Guardrails for Patients, Ambulances Drive Surprise Medical Billing
Studies show that at least half of ground ambulance rides across the nation leave patients with “surprise” medical bills. And a $300-a-mile ride is not unusual. Yet federal legislation to stem what’s known as balance billing has largely ignored ambulance costs.
Health Insurers Prosper As COVID-19 Deflates Demand For Elective Treatments
With most nonemergency procedures shelved for now, many health insurers are expected to see profits in the near term, but the longer view of how the coronavirus will affect them is far more complicated and could well impact what people pay for coverage next year.
‘An Arm And A Leg’: Am I Protected If I Need COVID-19 Care?
“An Arm and a Leg” is back sharing stories about the ways COVID-19 intersects with the cost of health care. To tackle a listener’s question about health coverage, Dan Weissmann spoke with one of the country’s top insurance nerds.
In Fine Print, HHS Appears To Ban All Surprise Billing During The Pandemic
Language in the CARES Act says providers who take emergency funding cannot balance-bill coronavirus patients ― and “every patient” is considered a possible COVID-19 patient.
With Federal Nod, Consumers Could Lose The Boost They Get From Drug ‘Coupons’
The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies’ assistance doesn’t count toward their members’ deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.